Ypsilon Receives $2.7 Million Non-Dilutive Grant to Advance Next-Generation TCRm Antibodies
Ypsilon Therapeutics, a portfolio company of 82VS, Alloy’s venture studio, has been awarded $2.7 million in seed funding from ...
Here's When Each Generation Starts Investing. How Do You Compare?
Not too long ago, people began investing in their mid-30s. Now, it’s common to see kids investing in their late teens.
General Dynamics Has a Differentiated Portfolio of Defense Contracting Capabilities
Before the Covid-19 pandemic, General Dynamics maintained one of the best balance sheets among the large public defense contractors. General Dynamics issued some debt in 2020 due to pandemic-related ...